Merko Ehitus AS
F:MKS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Merko Ehitus AS
F:MKS
|
EE |
|
G
|
Grupo Gicsa SAB de CV
BMV:GICSAB
|
MX |
|
Nuvation Bio Inc
NYSE:NUVB
|
US |
|
P
|
PS Tec Co Ltd
KOSDAQ:002230
|
KR |
|
Ramsdens Holdings PLC
LSE:RFX
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MKS's stock price target?
Not Available
MKS doesn't have any price targets made by Wall Street professionals.
What is Merko Ehitus AS's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Merko Ehitus AS's revenue is
3%.
The projected
CAGR
for the next 2 years is
8%.
What is Merko Ehitus AS's Operating Income forecast?
Projected CAGR
-30%
The
compound annual growth rate
of Merko Ehitus AS's operating income for the next 3 years is
-30%.
What is Merko Ehitus AS's Net Income forecast?
Projected CAGR
-43%
The
compound annual growth rate
of Merko Ehitus AS's net income for the next 2 years is
-43%.
